Clinical trial
A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
NCT01900054 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
- Lead sponsor
- Tanabe Pharma Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- November 30, 2013
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
perennial allergic rhinitis